STARGARDT DISEASE 1
Clinical trials for STARGARDT DISEASE 1 explained in plain language.
Never miss a new study
Get alerted when new STARGARDT DISEASE 1 trials appear
Sign up with your email to follow new studies for STARGARDT DISEASE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial offers hope for rare eye disease
Disease control Recruiting nowThis early-stage trial tests a new gene therapy called VG801 for people with Stargardt disease, an inherited condition that causes vision loss. The study involves 15 participants aged 6 and older who will receive a single injection under the retina. The main goal is to check safe…
Matched conditions: STARGARDT DISEASE 1
Phase: PHASE1, PHASE2 • Sponsor: VeonGen Therapeutics GmbH • Aim: Disease control
Last updated May 26, 2026 08:07 UTC
-
Gene therapy injection aims to slow vision loss in stargardt disease
Disease control Recruiting nowThis early study tests a single injection of ACDN-01 into the eye for people with Stargardt disease or related vision loss caused by ABCA4 gene mutations. The main goal is to check safety and find the best dose. Up to 15 adults with advanced vision loss will take part. The therap…
Matched conditions: STARGARDT DISEASE 1
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Eye disease prescreening opens door to future gene therapy trials
Knowledge-focused Recruiting nowThis study is a prescreening step to find people with a specific genetic eye condition called ABCA4-related retinopathy, which includes Stargardt disease and cone-rod dystrophy. About 50 participants will undergo genetic testing and eye exams to see if they qualify for future tri…
Matched conditions: STARGARDT DISEASE 1
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated May 26, 2026 08:22 UTC